PMID- 14759418 OWN - NLM STAT- MEDLINE DCOM- 20040317 LR - 20131121 IS - 0003-4975 (Print) IS - 0003-4975 (Linking) VI - 77 IP - 2 DP - 2004 Feb TI - Late results of palliative atrial switch for transposition, ventricular septal defect, and pulmonary vascular obstructive disease. PG - 464-8; discussion 468-9 AB - BACKGROUND: Palliative atrial switch (PAS) procedures that reroute pulmonary and systemic venous drainage and leave a ventricular septal defect (VSD) open have been used in the treatment of deeply cyanotic patients who have severe pulmonary vascular obstructive disease (PVOD). Palliative atrial switch is beneficial for patients with transposition of the great arteries or other complex lesions with VSD who show higher arterial oxygen saturation in the pulmonary artery than in the aorta (transposition hemodynamics/unfavorable streaming). We reviewed the early and late results of PAS (Mustard, n = 25; Senning, n = 3) in patients at two institutions. METHODS: Between April 1965 and March 2000, PAS was performed in 28 cyanotic patients (18 male, 10 female). Median age was 10 years (range, 1 to 27). Mean preoperative pulmonary arterial pressure was 68 mm Hg (range, 30 to 121 mm Hg). Mean systemic arterial oxygen saturation was 65% (range, 47% to 80%). The majority of patients (95%) were in New York Heart Association (NYHA) functional class III or IV preoperatively. RESULTS: Overall early mortality was 21%; for patients after 1972 (n = 23), the early mortality was 8.7%. Mean follow-up was 8.3 years (maximum 20). Mean postoperative systemic arterial oxygen saturation was increased significantly to 88% (p < 0.0001). Late survival for early survivors at 5, 10, and 15 years respectively was 84% (59%, 97%), 64% (39%, 88%), and 54% (15%, 72%). The NYHA functional class was significantly improved; 94% of late survivors (n = 17) were in functional class I or II (p = 0.002). CONCLUSIONS: The PAS operation significantly improves systemic arterial oxygen saturation and quality of life in selected patients with transposition hemodynamics, VSD, and severe PVOD. FAU - Burkhart, Harold M AU - Burkhart HM AD - Division of Cardiovascular Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota USA. FAU - Dearani, Joseph A AU - Dearani JA FAU - Williams, William G AU - Williams WG FAU - Puga, Francisco J AU - Puga FJ FAU - Mair, Douglas D AU - Mair DD FAU - Ashburn, David A AU - Ashburn DA FAU - Webb, Gary D AU - Webb GD FAU - Danielson, Gordon K AU - Danielson GK LA - eng PT - Journal Article PL - Netherlands TA - Ann Thorac Surg JT - The Annals of thoracic surgery JID - 15030100R RN - S88TT14065 (Oxygen) SB - IM MH - Adolescent MH - Adult MH - Child MH - Child, Preschool MH - Female MH - Follow-Up Studies MH - Heart Atria/*surgery MH - Heart Septal Defects, Ventricular/mortality/*surgery MH - Humans MH - Infant MH - Infant, Newborn MH - Male MH - Oxygen/blood MH - *Palliative Care MH - Postoperative Complications/*etiology/mortality MH - Pulmonary Veno-Occlusive Disease/*congenital/mortality/*surgery MH - Reoperation MH - Retrospective Studies MH - Survival Rate MH - Transposition of Great Vessels/mortality/*surgery EDAT- 2004/02/05 05:00 MHDA- 2004/03/18 05:00 CRDT- 2004/02/05 05:00 PHST- 2004/02/05 05:00 [pubmed] PHST- 2004/03/18 05:00 [medline] PHST- 2004/02/05 05:00 [entrez] AID - S0003497503013493 [pii] AID - 10.1016/S0003-4975(03)01349-3 [doi] PST - ppublish SO - Ann Thorac Surg. 2004 Feb;77(2):464-8; discussion 468-9. doi: 10.1016/S0003-4975(03)01349-3.